

A huge conflict has arisen between companies producing generic, more affordable drugs, and the big pharmaceutical companies. The multi-billion dollar

Scientists and biomedical researchers working at the Institute for Research in Biomedicine (IRB) in Barcelona, Spain have recently starred in